Share Name Share Symbol Market Type Share ISIN Share Description
Biotech Growth Trust (the) Plc LSE:BIOG London Ordinary Share GB0000385517 ORD 25P
  Price Change % Change Share Price Shares Traded Last Trade
  19.50 2.04% 977.00 28,489 16:35:22
Bid Price Offer Price High Price Low Price Open Price
976.00 978.00 978.00 966.00 966.00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Equity Investment Instruments 1.08 0.16 400
Last Trade Time Trade Type Trade Size Trade Price Currency
16:37:53 O 2,966 972.29 GBX

Biotech Growth (BIOG) Latest News (2)

More Biotech Growth News
Biotech Growth Investors    Biotech Growth Takeover Rumours

Biotech Growth (BIOG) Discussions and Chat

Biotech Growth Forums and Chat

Date Time Title Posts
13/1/202316:24Biotech Growth Trust PLC (The)366

Add a New Thread

Biotech Growth (BIOG) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type
View all Biotech Growth trades in real-time

Biotech Growth (BIOG) Top Chat Posts

Top Posts
Posted at 04/2/2023 08:20 by Biotech Growth Daily Update
Biotech Growth Trust (the) Plc is listed in the Equity Investment Instruments sector of the London Stock Exchange with ticker BIOG. The last closing price for Biotech Growth was 957.50p.
Biotech Growth Trust (the) Plc has a 4 week average price of 898p and a 12 week average price of 882p.
The 1 year high share price is 1,048p while the 1 year low share price is currently 725p.
There are currently 40,921,729 shares in issue and the average daily traded volume is 29,221 shares. The market capitalisation of Biotech Growth Trust (the) Plc is £399,805,292.33.
Posted at 16/11/2022 07:54 by ali47fish
biog update new chair some improvement
Posted at 14/6/2022 14:47 by daveoz1
Quote from above "By the standards of 2008 / 2009, this little Investment Trust has had a reasonably decent year". !!! What does that mean? When was that written? Am I missing something? Since March 2021, the Biotech Growth Trust price has plummeted by 50%! My worst investment by far.
Posted at 09/12/2021 11:31 by steeplejack
Questor in Daily Telegraph (9 Dec) recommends BIOG after marked underperformance in 2021.
Posted at 29/11/2021 19:03 by steeplejack
Oh dear,not popular comments i see.Thing is,over the last five years,BIOG is up 57%,over the same period SMT is up 375%.Investment is about opportunity cost as we all know.Now compared with Astra or Pfizer,the underperformance is that much less,over five years the former is up 97% and the latter up 77%.(Generously,i217;m ignoring management costs attaching to BIOG.)I’m really trying to justify why,on its track record,i should continue to hold this trust especially given its rather ‘risk averse’construct.It appears to be a rather broad simple proxy for biotech per se which means even a major success of one of the constituents is unlikely to meaningful alter the NAV.
Posted at 28/7/2021 15:47 by daveoz1
Absolutely ali47fish - I did a lot of investing about 4 months ago and BIOG has been by far the worst performing fund of those that I bought then, especially in the last few days! Finding it very hard to find out reasons for this. Slightly better today, but I'm hoping it improves a LOT more!
Posted at 16/7/2021 10:52 by tomps2
John Rosier mentions Biotech Growth (BIOG) in the latest PIWORLD interview at 12m14s

Watch the video here: Https://

Or listen to the podcast here: Https://

Posted at 09/6/2021 06:11 by steeplejack
2.5% of BIOG portfolio represented by Biogen which jumped some 40% in the US yesterday following FDA approval of its Alzheimer drug.
Posted at 06/3/2021 19:31 by cliff007
Ali. That's what I meant. I'm wondering what's going on. Another Investment Trust I have WWH, has suffered the same fate so I don't believe it's BIOG specific. I'm holding on.....
Posted at 06/3/2021 18:41 by shaker44
Could go lower of course. Markets jittery. But price now will look low later this year imo
Posted at 12/12/2020 20:17 by caradog
AstraZeneca to take over Alexion, which was BIOGs biggest holding on 31 Oct at 5.1% of the portfolio when Alexion’s share price was about $114. The cash and share deal is worth about $175 - a 45% premium on last quoted price.
Biotech Growth share price data is direct from the London Stock Exchange
Your Recent History
Biotech Gr..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20230205 05:42:37